Book contents
- Frontmatter
- 1 Introduction
- PART I WORKERS AND PLACES
- 2 Amateurs and Professionals
- 3 Discovery and Exploration
- 4 Museums
- 5 Field Stations and Surveys
- 6 Universities
- 7 Geological Industries
- 8 The Pharmaceutical Industries
- 9 Public and Environmental Health
- PART II ANALYSIS AND EXPERIMENTATION
- PART III NEW OBJECTS AND IDEAS
- PART IV SCIENCE AND CULTURE
- Index
- References
8 - The Pharmaceutical Industries
from PART I - WORKERS AND PLACES
Published online by Cambridge University Press: 28 November 2009
By
Book contents
- Frontmatter
- 1 Introduction
- PART I WORKERS AND PLACES
- 2 Amateurs and Professionals
- 3 Discovery and Exploration
- 4 Museums
- 5 Field Stations and Surveys
- 6 Universities
- 7 Geological Industries
- 8 The Pharmaceutical Industries
- 9 Public and Environmental Health
- PART II ANALYSIS AND EXPERIMENTATION
- PART III NEW OBJECTS AND IDEAS
- PART IV SCIENCE AND CULTURE
- Index
- References
Summary
Despite its importance and impact on our daily lives, the pharmaceutical industry has not attracted nearly as much attention as many other areas in the history of science and medicine. It is not entirely clear why this is the case, though it is not for lack of reminders in the popular press. The elusiveness of primary documentation on the pharmaceutical industry may help explain the lag in scholarly historical inquiries. But whatever the reason, more scrutiny is merited. Pharmaceuticals is one of the most research-intensive industries, it is an entity that usurped a central function of the pharmacist by the late nineteenth century, and it arguably can (and does) label itself the primary broker in the chemotherapeutic revolution of the twentieth century. It has been as consistently profitable throughout the twentieth century as any corner of the private sector; the global market for pharmaceuticals by the mid-1990s was estimated by one source to be $200 billion (U.S.) annually. By 2000, that figure had climbed to $317 billion, with North America accounting for about half that amount. Pharmaceuticals is also an enterprise that can produce drugs like thalidomide, a medicine emblematic of therapeutics gone wrong – and drug regulation simply gone. In the legislatures of the world’s leading producers of pharmaceuticals, the drug industry and its trade groups wield considerable influence. Therefore, the lag in historical attention to this industry cannot be for lack of impact by the subject.
- Type
- Chapter
- Information
- The Cambridge History of Science , pp. 126 - 140Publisher: Cambridge University PressPrint publication year: 2009
References
, A History of the International Chemical Industry, trans. Otto Theodor Benfy (Philadelphia: University of Pennsylvania Press, 1991);Google Scholar
and , Wealth of Contrasts: Nyegaard & Co., a Norwegian Pharmaceutical Company, 1874–1985 (n.p.: Ad Notam Gyldendal, 1994), 62.Google Scholar
, Farben, Formeln, Forscher: Hoechst und die Geschichte der industriellen Chemie in Deutschland (Munich: Piper, 1989);Google Scholar
, , and , The World’s Pharmaceutical Industries: An International Perspective on Innovation, Competition and Policy (Hants: Edward Elgar, 1992).Google Scholar
, “Coal Tar Dye Manufacture and the Origins of the Modern Industrial Research Laboratory,” Isis, 49 (1958).CrossRefGoogle Scholar
et al., History of Pharmacy and Pharmaceutical Industry (Paris: Asklepios Press, ca. 1982).Google Scholar
, “The Development of an International Business Information Service for the Pharmaceutical Industry,” Pharmaceutical Historian, 24 (March 1994);Google ScholarPubMed
et al., “Thalidomide, a Current Teratogen in South America,” Teratology: The Journal of Abnormal Development, 54 (1996);3.0.CO;2-#>CrossRefGoogle ScholarPubMed
, In Health and in Sickness: Pharmacy, Pharmacists, and the Pharmaceutical Industry in Late Imperial, Early Soviet Russia (Boulder, Colo.: East European Monographs, 1994)Google Scholar
, Plough Court: The Story of a Notable Pharmacy, 1715–1927 (London: Allen and Hanbury’s, 1927);Google Scholar
, “Joseph Pelletier and Joseph Caventou,” trans. Ralph E. Oesper, Journal of Chemical Education, 28 (1951);CrossRefGoogle Scholar
and , Making Medicine, Making Money (Kansas City, Mo.: Universal Press Syndicate, 1993),Google Scholar
, Pharmaceutical Conditions and Drug Supply in the Confederacy, Contributions from the History of Pharmacy Department of the School of Pharmacy, University of Wisconsin, No. 3 (Madison, Wis.: American Institute of the History of Pharmacy, 1955).Google Scholar
and , The Story of Taxol: Nature and Politics in the Pursuit of an Anti-cancer Drug (Cambridge: Cambridge University Press, 2001)Google Scholar
and , eds., The History of Pharmacy: A Selected Annotated Bibliography (New York: Garland, 1995).Google Scholar
, “Evolution of Pharmacy,” in Remington’s Pharmaceutical Sciences, 18th ed., ed. (Easton, Pa.: Mack, 1990), p..Google Scholar
, In Service to American Pharmacy: The Professional Life of William Procter, Jr. (Tuscaloosa: University of Alabama Press, 1992).Google Scholar
, Penicillin: Meeting the Challenge (New Haven, Conn.: Yale University Press, 1985).CrossRefGoogle Scholar
, “Biologics Control Act of 1902,” in The Early Years of Federal Food and Drug Control, ed. (Madison, Wis.: American Institute of the History of Pharmacy, 1982).Google Scholar
and , History of Pharmacy: A Guide and a Survey, 1st ed. (Philadelphia: Lippincott, 1940), p.;Google Scholar
, Friedrich Wilh. Serturner, der Entdecker des Morphiums (Jena: Gustav Fischer, 1925).Google Scholar
, , and , eds., Pharmaceutical Innovation: Revolutionizing Human Health (Philadelphia: Chemical Heritage Press, 1999)Google Scholar
, “Conceptual Change in an Empirical Science: The Discovery of the First Alkaloids,” Historical Studies in the Physical Sciences, 11 (1981);CrossRefGoogle Scholar
and , Prices of Drugs and Pharmaceuticals, War Industries Board Price Bulletin 54 (Washington, D.C.: U.S. Government Printing Office, 1919).Google Scholar
, Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry (Baltimore: Johns Hopkins University Press, 1987), p..CrossRefGoogle Scholar
, “Friedrich Wilhelm Serturner, the Discoverer of Morphine,” trans. Ralph E. Oesper, Journal of Chemical Education, 28 (1951);Google Scholar
, The Merchants of Life: An Account of the American Pharmaceutical Industry (New York: Harper and Brothers, 1959), p..Google Scholar
and , The Aspirin Wars: Money, Medicine, and 100 Years of Rampant Competition (New York: Random House, 1991).Google Scholar
, “The Introduction of Antibiotics into Therapeutics,” in History of Therapy, ed. et al. (Tokyo: Ishiyaku Euro America, 1990), p..Google Scholar
, “A Brief History of the Pharmaceutical Industry in Basel,” in Pill Peddlers: Essays on the History of the Pharmaceutical Industry, ed. , , and (Madison, Wis.: American Institute of the History of Pharmacy, 1990).Google Scholar
, Chronik der Hoechst Aktiengesellschaft, 1863–1988 (Frankfurt am Main: Hoechst, 1990).Google Scholar
, The Enchanted Ring: The Untold Story of Penicillin (Cambridge, Mass.: MIT Press, 1982).Google Scholar
, The Drugging of the Americas: How Multinational Drug Companies Say One Thing about Their Products to Physicians in the United States, and Another Thing to Physicians in Latin America (Berkeley: University of California Press, 1976)Google Scholar
, , and , Prescriptions for Death: The Drugging of the Third World (Berkeley: University of California Press, 1982).Google Scholar
, , and , Bad Medicine: The Prescription Drug Industry in the Third World (Stanford, Calif.: Stanford University Press, 1992).Google Scholar
, Medicines for the Union Army: The United States Army Laboratories during the Civil War (Madison, Wis.: American Institute of the History of Pharmacy, 1962).Google Scholar
, Academic Scientists and the Pharmaceutical Industry: Cooperative Research in Twentieth-Century America (Baltimore: Johns Hopkins University Press, 1988).Google Scholar
, “The Discovery and Early Development of Penicillin,” Medical Heritage, 1, no. 5 (1985).Google ScholarPubMed
, “Evolution of the American Pharmaceutical Industry,” Pharmacy in History, 37 (1995).Google ScholarPubMed
, “Pills, Profits and Propriety: The Early Pharmaceutical Industry in Britain,” Pharmaceutical Historian, 25 (December 1995).Google ScholarPubMed
, At the Sign of the Plough: 275 Years of Allen & Hanburys and the British Pharmaceutical Industry (London: John Murray, 1990);Google Scholar
, “Retail Pharmacy as the Nucleus of the Pharmaceutical Industry,” Supplements to the Bulletin of the History of Medicine, no. 3 (1944),Google Scholar
, “’Antibiotic Abandon’: The Resurgence of Therapeutic Rationalism,” in The History of Antibiotics: A Symposium, ed. (Madison, Wis.: American Institute of the History of Pharmacy, 1980).Google Scholar
, “The Process of Development from Apothecary Activity into Pharmaceutical Industry in Hungary,” in Farmacia e Industrializacion: Libro Homenaje al Doctor Guillermo Folch Jou, ed. (Madrid: Sociedad Espanola de Historia de la Farmacia, 1985).Google Scholar